FOLFOX-A in the Treatment of Metastatic or Advanced Unresectable Gastric, Gastro-Esophageal Junction Adenocarcinoma
Clinical trial NCT03283761 · COMPLETED
Trial details
- NCT number
- NCT03283761
- Sponsor
- Al B. Benson, III, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-09-21
- Primary completion
- 2022-12-27
- Enrollment
- 39
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.